Summarize this content to 2000 words in 6 paragraphs
Kirkland, Wash.-based Kestra Medical Technologies raised $202 million in its initial public offering, pricing shares at $17.
That’s higher than the company’s initial plan to price shares between $14 and $16. Kestra also offered more shares than expected.
The maker of cardiac monitoring and therapeutic devices plans to start trading on the Nasdaq on Thursday under the ticker “KMTS.”
Kestra launched in 2014 and raised a $196 million round from private investors last year. More than 550 hospitals have prescribed its system, which has been worn by more than 17,000 patients, according to the company’s regulatory filing. It employs more than 300 people.
Previously: Kestra Medical Technologies, maker of wearable cardiac devices, files for IPO
